| 0 |
SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, HYPERSOMNIA TYPE |
2 |
0.0190 |
| 1 |
ONYCHOMADESIS |
63 |
0.0150 |
| 2 |
RHEUMATIC FEVER |
66 |
0.0148 |
| 3 |
ONYCHOMYCOSIS |
64 |
0.0146 |
| 4 |
ACQUIRED PORPHYRIA |
1 |
0.0141 |
| 5 |
C-REACTIVE PROTEIN ABNORMAL |
61 |
0.0095 |
| 6 |
HEPATIC ENZYME |
1 |
0.0067 |
| 7 |
FACET JOINT SYNDROME |
21 |
0.0064 |
| 8 |
HYPOCHOLESTEROLAEMIA |
2 |
0.0057 |
| 9 |
PEMPHIGUS |
68 |
0.0054 |
| 10 |
EOSINOPHIL PERCENTAGE DECREASED |
1 |
0.0050 |
| 11 |
PERIPHERAL VENOUS DISEASE |
20 |
0.0049 |
| 12 |
RENAL CORTICAL NECROSIS |
1 |
0.0043 |
| 13 |
PERICARDITIS |
69 |
0.0041 |
| 14 |
BLEPHAROSPASM |
23 |
0.0036 |
| 15 |
SYNOVITIS |
64 |
0.0035 |
| 16 |
WOUND INFECTION PSEUDOMONAS |
1 |
0.0032 |
| 17 |
CARBON DIOXIDE ABNORMAL |
1 |
0.0032 |
| 18 |
HYPERAESTHESIA TEETH |
4 |
0.0032 |
| 19 |
BACK INJURY |
30 |
0.0028 |
| 20 |
MYOSCLEROSIS |
1 |
0.0027 |
| 21 |
BREAST CANCER STAGE III |
17 |
0.0026 |
| 22 |
ALKALOSIS |
1 |
0.0026 |
| 23 |
ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC |
4 |
0.0026 |
| 24 |
UPPER EXTREMITY MASS |
1 |
0.0026 |
| 25 |
PRODUCT LABEL CONFUSION |
15 |
0.0026 |
| 26 |
WOUND |
71 |
0.0025 |
| 27 |
MUSCLE INJURY |
21 |
0.0025 |
| 28 |
LYMPHOCYTE PERCENTAGE INCREASED |
1 |
0.0025 |
| 29 |
DUODENAL ULCER PERFORATION |
17 |
0.0023 |
| 30 |
FINGER DEFORMITY |
11 |
0.0023 |
| 31 |
DEGENERATIVE BONE DISEASE |
1 |
0.0023 |
| 32 |
BILIARY SEPSIS |
1 |
0.0022 |
| 33 |
SKIN FIBROSIS |
1 |
0.0021 |
| 34 |
TYPE 2 DIABETES MELLITUS |
69 |
0.0020 |
| 35 |
CONTRAINDICATED PRODUCT ADMINISTERED |
62 |
0.0020 |
| 36 |
SYSTEMIC LUPUS ERYTHEMATOSUS |
68 |
0.0019 |
| 37 |
NEUTROPHIL PERCENTAGE DECREASED |
1 |
0.0019 |
| 38 |
ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE |
13 |
0.0018 |
| 39 |
PRESBYOPIA |
1 |
0.0018 |
| 40 |
C-REACTIVE PROTEIN INCREASED |
65 |
0.0018 |
| 41 |
SUBCUTANEOUS DRUG ABSORPTION IMPAIRED |
1 |
0.0018 |
| 42 |
EUSTACHIAN TUBE DYSFUNCTION |
1 |
0.0017 |
| 43 |
WOUND INFECTION |
19 |
0.0017 |
| 44 |
BURSITIS |
21 |
0.0017 |
| 45 |
PSORIATIC ARTHROPATHY |
69 |
0.0017 |
| 46 |
X-RAY ABNORMAL |
3 |
0.0017 |
| 47 |
URINARY TRACT INFECTION PSEUDOMONAL |
1 |
0.0017 |
| 48 |
HYPERCHOLESTEROLAEMIA |
16 |
0.0017 |
| 49 |
NORMAL NEWBORN |
9 |
0.0017 |
| 50 |
CARDIAC PROCEDURE COMPLICATION |
1 |
0.0016 |
| 51 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
70 |
0.0016 |
| 52 |
LIP DRY |
13 |
0.0014 |
| 53 |
OVERLAP SYNDROME |
1 |
0.0014 |
| 54 |
NAIL DISORDER |
12 |
0.0014 |
| 55 |
INFUSION SITE REACTION |
4 |
0.0013 |
| 56 |
OBESITY |
20 |
0.0013 |
| 57 |
GRIP STRENGTH DECREASED |
11 |
0.0012 |
| 58 |
FOLLICULITIS |
13 |
0.0012 |
| 59 |
BOTULISM |
1 |
0.0012 |
| 60 |
TASTE DISORDER |
23 |
0.0011 |
| 61 |
LUNG TRANSPLANT |
4 |
0.0011 |
| 62 |
JOINT RANGE OF MOTION DECREASED |
15 |
0.0011 |
| 63 |
INCISION SITE INFECTION |
1 |
0.0011 |
| 64 |
CERUMEN IMPACTION |
1 |
0.0011 |
| 65 |
LIVE BIRTH |
9 |
0.0011 |
| 66 |
HELICOBACTER INFECTION |
11 |
0.0011 |
| 67 |
ILL-DEFINED DISORDER |
64 |
0.0011 |
| 68 |
HIGH DENSITY LIPOPROTEIN INCREASED |
1 |
0.0010 |
| 69 |
INFUSION RELATED REACTION |
64 |
0.0010 |
| 70 |
INJECTION SITE REACTION |
64 |
0.0009 |
| 71 |
SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE |
6 |
0.0009 |
| 72 |
SLEEP DISORDER |
65 |
0.0009 |
| 73 |
COELIAC DISEASE |
9 |
0.0009 |
| 74 |
SOFT TISSUE DISORDER |
1 |
0.0009 |
| 75 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
64 |
0.0009 |
| 76 |
RED BLOOD CELL SEDIMENTATION RATE ABNORMAL |
2 |
0.0009 |
| 77 |
TREATMENT FAILURE |
71 |
0.0009 |
| 78 |
LUPUS VULGARIS |
1 |
0.0008 |
| 79 |
ASPERGILLOSIS |
1 |
0.0008 |
| 80 |
HAND DEFORMITY |
10 |
0.0008 |
| 81 |
HYPOVITAMINOSIS |
1 |
0.0008 |
| 82 |
EPILEPSY |
23 |
0.0008 |
| 83 |
ANION GAP INCREASED |
1 |
0.0007 |
| 84 |
GAIT INABILITY |
24 |
0.0007 |
| 85 |
PURULENT DISCHARGE |
3 |
0.0007 |
| 86 |
PELVIC VENOUS THROMBOSIS |
1 |
0.0007 |
| 87 |
LIVER INJURY |
17 |
0.0007 |
| 88 |
RHEUMATOID FACTOR POSITIVE |
4 |
0.0007 |
| 89 |
UNDERDOSE |
50 |
0.0007 |
| 90 |
INTENTIONAL PRODUCT USE ISSUE |
60 |
0.0007 |
| 91 |
SWELLING |
62 |
0.0007 |
| 92 |
FIBROMYALGIA |
16 |
0.0007 |
| 93 |
JOINT DESTRUCTION |
1 |
0.0006 |
| 94 |
OPHTHALMOPLEGIA |
1 |
0.0006 |
| 95 |
GLOSSODYNIA |
14 |
0.0006 |
| 96 |
IRRITABLE BOWEL SYNDROME |
13 |
0.0006 |
| 97 |
ADVERSE REACTION |
8 |
0.0006 |
| 98 |
GAZE PALSY |
1 |
0.0006 |
| 99 |
RETINITIS |
1 |
0.0006 |
| 100 |
WOUND INFECTION STAPHYLOCOCCAL |
1 |
0.0006 |
| 101 |
RHEUMATOID ARTHRITIS |
65 |
0.0006 |
| 102 |
RIGHT VENTRICULAR FAILURE |
4 |
0.0006 |
| 103 |
OSTEOARTHRITIS |
24 |
0.0006 |
| 104 |
INCORRECT PRODUCT ADMINISTRATION DURATION |
12 |
0.0006 |
| 105 |
LIVER FUNCTION TEST INCREASED |
11 |
0.0005 |
| 106 |
NASAL SEPTUM DEVIATION |
1 |
0.0005 |
| 107 |
DEEP VEIN THROMBOSIS POSTOPERATIVE |
1 |
0.0005 |
| 108 |
PERIPHERAL ISCHAEMIA |
2 |
0.0005 |
| 109 |
WHEEZING |
29 |
0.0005 |
| 110 |
IMPAIRED HEALING |
16 |
0.0005 |
| 111 |
UPPER-AIRWAY COUGH SYNDROME |
4 |
0.0005 |
| 112 |
ADJUSTMENT DISORDER WITH DEPRESSED MOOD |
1 |
0.0005 |
| 113 |
SKIN INDURATION |
1 |
0.0005 |
| 114 |
DRUG-INDUCED LIVER INJURY |
15 |
0.0005 |
| 115 |
DEREALISATION |
1 |
0.0005 |
| 116 |
URINE OUTPUT DECREASED |
4 |
0.0005 |
| 117 |
CONFUSIONAL STATE |
71 |
0.0004 |
| 118 |
DISLOCATION OF VERTEBRA |
1 |
0.0004 |
| 119 |
NIGHT SWEATS |
14 |
0.0004 |
| 120 |
EYELID DISORDER |
1 |
0.0004 |
| 121 |
CONTRAST MEDIA REACTION |
1 |
0.0004 |
| 122 |
THERAPY CHANGE |
4 |
0.0004 |
| 123 |
BLOOD PRESSURE SYSTOLIC ABNORMAL |
1 |
0.0004 |
| 124 |
CANCER PAIN |
1 |
0.0004 |
| 125 |
HEPATITIS |
10 |
0.0004 |
| 126 |
DISSEMINATED TUBERCULOSIS |
1 |
0.0004 |
| 127 |
MEAN CELL VOLUME INCREASED |
1 |
0.0004 |
| 128 |
BLOOD CHLORIDE DECREASED |
1 |
0.0004 |
| 129 |
STOMATITIS |
23 |
0.0004 |
| 130 |
LOWER RESPIRATORY TRACT INFECTION |
17 |
0.0004 |
| 131 |
DRUG TOLERANCE DECREASED |
1 |
0.0004 |
| 132 |
SKIN HYPERTROPHY |
1 |
0.0004 |
| 133 |
CHOLECYSTITIS ACUTE |
2 |
0.0004 |
| 134 |
PRODUCT USE ISSUE |
66 |
0.0004 |
| 135 |
DERMATITIS CONTACT |
4 |
0.0004 |
| 136 |
NEPHROGENIC SYSTEMIC FIBROSIS |
1 |
0.0003 |
| 137 |
LUPUS-LIKE SYNDROME |
3 |
0.0003 |
| 138 |
ECONOMIC PROBLEM |
5 |
0.0003 |
| 139 |
EYE INJURY |
1 |
0.0003 |
| 140 |
EXOSTOSIS |
3 |
0.0003 |
| 141 |
LUNG DISORDER |
16 |
0.0003 |
| 142 |
GENERALISED OEDEMA |
4 |
0.0003 |
| 143 |
SCIATICA |
5 |
0.0003 |
| 144 |
SWOLLEN JOINT COUNT INCREASED |
1 |
0.0003 |
| 145 |
PORTAL VEIN THROMBOSIS |
1 |
0.0003 |
| 146 |
HIATUS HERNIA |
4 |
0.0003 |
| 147 |
DEAFNESS NEUROSENSORY |
1 |
0.0003 |
| 148 |
PUSTULAR PSORIASIS |
1 |
0.0003 |
| 149 |
HYPERTRANSAMINASAEMIA |
2 |
0.0003 |
| 150 |
BONE EROSION |
1 |
0.0003 |
| 151 |
PULMONARY ARTERIAL HYPERTENSION |
4 |
0.0003 |
| 152 |
RED BLOOD CELL SEDIMENTATION RATE INCREASED |
3 |
0.0003 |
| 153 |
PRODUCT USE IN UNAPPROVED INDICATION |
67 |
0.0003 |
| 154 |
MATERNAL EXPOSURE TIMING UNSPECIFIED |
1 |
0.0003 |
| 155 |
PROTEIN TOTAL DECREASED |
1 |
0.0003 |
| 156 |
MOBILITY DECREASED |
19 |
0.0003 |
| 157 |
OVERDOSE |
57 |
0.0003 |
| 158 |
DRY MOUTH |
21 |
0.0003 |
| 159 |
PATENT DUCTUS ARTERIOSUS |
1 |
0.0003 |
| 160 |
MUSCLE FATIGUE |
1 |
0.0002 |
| 161 |
METASTATIC NEOPLASM |
1 |
0.0002 |
| 162 |
AMENORRHOEA |
4 |
0.0002 |
| 163 |
ABDOMINAL ABSCESS |
1 |
0.0002 |
| 164 |
PHYSICAL DISABILITY |
1 |
0.0002 |
| 165 |
IRON DEFICIENCY |
1 |
0.0002 |
| 166 |
SUSPECTED OFF LABEL USE |
1 |
0.0002 |
| 167 |
INJURY |
15 |
0.0002 |
| 168 |
MATERNAL EXPOSURE DURING PREGNANCY |
19 |
0.0002 |
| 169 |
INFLAMMATION |
11 |
0.0002 |
| 170 |
SKIN TIGHTNESS |
1 |
0.0002 |
| 171 |
MIGRAINE |
20 |
0.0002 |
| 172 |
DRUG INTOLERANCE |
20 |
0.0002 |
| 173 |
RASH VESICULAR |
1 |
0.0002 |
| 174 |
HEPATIC ENZYME INCREASED |
14 |
0.0002 |
| 175 |
BONE LOSS |
3 |
0.0002 |
| 176 |
GASTROOESOPHAGEAL REFLUX DISEASE |
16 |
0.0002 |
| 177 |
OSTEOPENIA |
3 |
0.0002 |
| 178 |
NECK PAIN |
11 |
0.0002 |
| 179 |
AMMONIA INCREASED |
1 |
0.0002 |
| 180 |
BLOOD CHOLESTEROL INCREASED |
9 |
0.0002 |
| 181 |
BLOOD LACTIC ACID INCREASED |
1 |
0.0002 |
| 182 |
MULTIPLE FRACTURES |
3 |
0.0002 |
| 183 |
ARTHROPATHY |
10 |
0.0002 |
| 184 |
OBSTRUCTIVE AIRWAYS DISORDER |
2 |
0.0002 |
| 185 |
PRODUCT QUALITY ISSUE |
24 |
0.0002 |
| 186 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
3 |
0.0002 |
| 187 |
ENTEROCOLITIS |
1 |
0.0002 |
| 188 |
ASCITES |
5 |
0.0002 |
| 189 |
OEDEMA |
9 |
0.0002 |
| 190 |
RASH |
72 |
0.0002 |
| 191 |
CONCOMITANT DISEASE AGGRAVATED |
1 |
0.0002 |
| 192 |
EXPOSURE DURING PREGNANCY |
10 |
0.0002 |
| 193 |
BLISTER |
9 |
0.0002 |
| 194 |
HEPATIC CIRRHOSIS |
3 |
0.0002 |
| 195 |
HYPOPHAGIA |
4 |
0.0002 |
| 196 |
PULMONARY FIBROSIS |
3 |
0.0002 |
| 197 |
LOWER LIMB FRACTURE |
3 |
0.0002 |
| 198 |
EAR PAIN |
3 |
0.0002 |
| 199 |
MUSCULOSKELETAL PAIN |
8 |
0.0002 |
| 200 |
JOINT STIFFNESS |
4 |
0.0002 |
| 201 |
WRONG PRODUCT ADMINISTERED |
1 |
0.0001 |
| 202 |
ULCER HAEMORRHAGE |
1 |
0.0001 |
| 203 |
DISCOMFORT |
9 |
0.0001 |
| 204 |
PRODUCT LABEL ISSUE |
1 |
0.0001 |
| 205 |
DELIRIUM |
5 |
0.0001 |
| 206 |
PAIN IN JAW |
4 |
0.0001 |
| 207 |
MEMORY IMPAIRMENT |
19 |
0.0001 |
| 208 |
PERIPHERAL SWELLING |
21 |
0.0001 |
| 209 |
RESPIRATORY DISORDER |
4 |
0.0001 |
| 210 |
GENERAL SYMPTOM |
1 |
0.0001 |
| 211 |
DYSPEPSIA |
13 |
0.0001 |
| 212 |
RENAL FAILURE CHRONIC |
1 |
0.0001 |
| 213 |
PERICARDIAL EFFUSION |
3 |
0.0001 |
| 214 |
WEIGHT INCREASED |
29 |
0.0001 |
| 215 |
CONGENITAL ANOMALY |
1 |
0.0001 |
| 216 |
CONCUSSION |
1 |
0.0001 |
| 217 |
BLOOD ALBUMIN DECREASED |
1 |
0.0001 |
| 218 |
DYSPNOEA |
71 |
0.0001 |
| 219 |
ABDOMINAL DISTENSION |
13 |
0.0001 |
| 220 |
FRUSTRATION TOLERANCE DECREASED |
1 |
0.0001 |
| 221 |
STAPHYLOCOCCAL INFECTION |
4 |
0.0001 |
| 222 |
PARAESTHESIA |
19 |
0.0001 |
| 223 |
BREAST CANCER STAGE II |
1 |
0.0001 |
| 224 |
HAEMODIALYSIS |
1 |
0.0001 |
| 225 |
PAIN |
73 |
0.0001 |
| 226 |
SINUSITIS |
12 |
0.0001 |
| 227 |
SKIN HYPERPIGMENTATION |
1 |
0.0001 |
| 228 |
URTICARIA |
19 |
0.0001 |
| 229 |
GENERAL PHYSICAL HEALTH DETERIORATION |
13 |
0.0001 |
| 230 |
MYOSITIS |
1 |
0.0001 |
| 231 |
UPPER RESPIRATORY TRACT INFECTION |
5 |
0.0001 |
| 232 |
JOINT SWELLING |
13 |
0.0001 |
| 233 |
NEPHROPATHY |
1 |
0.0001 |
| 234 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
5 |
0.0001 |
| 235 |
MUSCULOSKELETAL STIFFNESS |
9 |
0.0001 |
| 236 |
AUTOIMMUNE DISORDER |
1 |
0.0001 |
| 237 |
VITAMIN D DEFICIENCY |
1 |
0.0001 |
| 238 |
RENAL TUBULAR NECROSIS |
1 |
0.0001 |
| 239 |
PREGNANCY |
2 |
0.0001 |
| 240 |
EYELID PTOSIS |
1 |
0.0001 |
| 241 |
ADVERSE EVENT |
9 |
0.0001 |
| 242 |
OSTEOPOROSIS |
4 |
0.0001 |
| 243 |
OFF LABEL USE |
85 |
0.0001 |
| 244 |
TEMPERATURE INTOLERANCE |
1 |
0.0001 |
| 245 |
SKELETAL INJURY |
1 |
0.0001 |
| 246 |
TOOTH LOSS |
2 |
0.0001 |
| 247 |
BONE DENSITY DECREASED |
3 |
0.0001 |
| 248 |
NAUSEA |
75 |
0.0001 |
| 249 |
DECREASED APPETITE |
22 |
0.0001 |
| 250 |
JOINT DISLOCATION |
1 |
0.0001 |
| 251 |
DECREASED ACTIVITY |
1 |
0.0001 |
| 252 |
OSTEONECROSIS |
3 |
0.0001 |
| 253 |
GASTROINTESTINAL PAIN |
1 |
0.0001 |
| 254 |
FOOT DEFORMITY |
1 |
0.0001 |
| 255 |
HYPERTENSIVE CRISIS |
1 |
0.0001 |
| 256 |
DEPRESSION |
20 |
0.0001 |
| 257 |
ADRENAL INSUFFICIENCY |
1 |
0.0001 |
| 258 |
PLEURAL EFFUSION |
5 |
0.0001 |
| 259 |
SMALL INTESTINAL OBSTRUCTION |
1 |
0.0001 |
| 260 |
HYPOAESTHESIA |
12 |
0.0001 |
| 261 |
GASTROINTESTINAL DISORDER |
7 |
0.0001 |
| 262 |
FALL |
26 |
0.0001 |
| 263 |
METASTASES TO CENTRAL NERVOUS SYSTEM |
1 |
0.0001 |
| 264 |
EAR INFECTION |
2 |
0.0001 |
| 265 |
MALIGNANT MELANOMA |
1 |
0.0001 |
| 266 |
QUALITY OF LIFE DECREASED |
1 |
0.0001 |
| 267 |
PERIPHERAL COLDNESS |
1 |
0.0001 |
| 268 |
HYPOMAGNESAEMIA |
1 |
0.0001 |
| 269 |
MUSCLE SPASMS |
13 |
0.0001 |
| 270 |
PARALYSIS |
1 |
0.0001 |
| 271 |
INFECTION |
10 |
0.0001 |
| 272 |
DYSSTASIA |
2 |
0.0001 |
| 273 |
LIVER DISORDER |
3 |
0.0001 |
| 274 |
PULMONARY MASS |
1 |
0.0001 |
| 275 |
IMMUNODEFICIENCY |
1 |
0.0001 |
| 276 |
ALOPECIA |
13 |
0.0001 |
| 277 |
HYPERTENSION |
14 |
0.0001 |
| 278 |
DEVICE RELATED INFECTION |
1 |
0.0001 |
| 279 |
HYPERSENSITIVITY |
12 |
0.0001 |
| 280 |
ABDOMINAL PAIN UPPER |
13 |
0.0001 |
| 281 |
PNEUMOTHORAX |
1 |
0.0001 |
| 282 |
RESPIRATORY TRACT CONGESTION |
1 |
0.0001 |
| 283 |
PREMATURE DELIVERY |
1 |
0.0001 |
| 284 |
CONTUSION |
6 |
0.0001 |
| 285 |
HIP FRACTURE |
2 |
0.0001 |
| 286 |
MUSCULAR WEAKNESS |
7 |
0.0001 |
| 287 |
BLOOD POTASSIUM INCREASED |
1 |
0.0001 |
| 288 |
BACK DISORDER |
1 |
0.0001 |
| 289 |
INSOMNIA |
16 |
0.0001 |
| 290 |
SKIN DISORDER |
2 |
0.0001 |
| 291 |
BLOOD UREA INCREASED |
1 |
0.0001 |
| 292 |
NASOPHARYNGITIS |
11 |
0.0001 |
| 293 |
ABDOMINAL DISCOMFORT |
10 |
0.0001 |
| 294 |
DRUG INEFFECTIVE |
78 |
0.0001 |
| 295 |
SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION |
1 |
0.0001 |
| 296 |
SCAR |
1 |
0.0001 |
| 297 |
NEUROTOXICITY |
1 |
0.0001 |
| 298 |
METASTASES TO LIVER |
1 |
0.0001 |
| 299 |
HYPOXIA |
2 |
0.0001 |
| 300 |
PANCREATITIS |
3 |
0.0001 |
| 301 |
BLOOD TRIGLYCERIDES INCREASED |
1 |
0.0001 |
| 302 |
DRUG ERUPTION |
1 |
0.0001 |
| 303 |
EYE SWELLING |
2 |
0.0001 |
| 304 |
DYSARTHRIA |
2 |
0.0001 |
| 305 |
HYPOCALCAEMIA |
1 |
0.0001 |
| 306 |
FRACTURE |
1 |
0.0001 |
| 307 |
FOOT FRACTURE |
1 |
0.0001 |
| 308 |
PROTEINURIA |
1 |
0.0001 |
| 309 |
WHITE BLOOD CELL COUNT INCREASED |
2 |
0.0001 |
| 310 |
HOSPITALISATION |
8 |
0.0001 |
| 311 |
PRESCRIBED OVERDOSE |
1 |
0.0001 |
| 312 |
KIDNEY INFECTION |
1 |
0.0001 |
| 313 |
DISABILITY |
1 |
0.0001 |
| 314 |
BLOOD PRESSURE ABNORMAL |
1 |
0.0001 |
| 315 |
PRESCRIBED UNDERDOSE |
1 |
0.0001 |
| 316 |
DIZZINESS |
25 |
0.0001 |
| 317 |
EMOTIONAL DISTRESS |
6 |
0.0000 |
| 318 |
CONDITION AGGRAVATED |
15 |
0.0000 |
| 319 |
RIB FRACTURE |
1 |
0.0000 |
| 320 |
RENAL IMPAIRMENT |
4 |
0.0000 |
| 321 |
RENAL FAILURE ACUTE |
2 |
0.0000 |
| 322 |
BLOOD CREATININE INCREASED |
3 |
0.0000 |
| 323 |
CLOSTRIDIUM DIFFICILE INFECTION |
1 |
0.0000 |
| 324 |
ASTHENIA |
17 |
0.0000 |
| 325 |
TRANSAMINASES INCREASED |
1 |
0.0000 |
| 326 |
COLITIS ULCERATIVE |
2 |
0.0000 |
| 327 |
RASH PAPULAR |
1 |
0.0000 |
| 328 |
SNEEZING |
1 |
0.0000 |
| 329 |
SKIN DISCOLOURATION |
2 |
0.0000 |
| 330 |
ABDOMINAL PAIN |
10 |
0.0000 |
| 331 |
RASH ERYTHEMATOUS |
2 |
0.0000 |
| 332 |
PRESYNCOPE |
1 |
0.0000 |
| 333 |
MALAISE |
18 |
0.0000 |
| 334 |
PAIN IN EXTREMITY |
12 |
0.0000 |
| 335 |
ENCEPHALOPATHY |
1 |
0.0000 |
| 336 |
PNEUMONIA |
13 |
0.0000 |
| 337 |
GLYCOSYLATED HAEMOGLOBIN INCREASED |
1 |
0.0000 |
| 338 |
DIPLOPIA |
1 |
0.0000 |
| 339 |
MUCOSAL INFLAMMATION |
1 |
0.0000 |
| 340 |
ANHEDONIA |
1 |
0.0000 |
| 341 |
BLOOD BILIRUBIN INCREASED |
1 |
0.0000 |
| 342 |
FREQUENT BOWEL MOVEMENTS |
1 |
0.0000 |
| 343 |
THROAT TIGHTNESS |
1 |
0.0000 |
| 344 |
LIMB INJURY |
1 |
0.0000 |
| 345 |
CARDIAC ARREST |
3 |
0.0000 |
| 346 |
RESPIRATORY DISTRESS |
1 |
0.0000 |
| 347 |
ARTHRALGIA |
15 |
0.0000 |
| 348 |
HAEMOPTYSIS |
1 |
0.0000 |
| 349 |
INTERNATIONAL NORMALISED RATIO INCREASED |
1 |
0.0000 |
| 350 |
LABORATORY TEST ABNORMAL |
1 |
0.0000 |
| 351 |
RENAL INJURY |
1 |
0.0000 |
| 352 |
ADVERSE DRUG REACTION |
3 |
0.0000 |
| 353 |
CORONARY ARTERY DISEASE |
1 |
0.0000 |
| 354 |
DRUG ADMINISTRATION ERROR |
1 |
0.0000 |
| 355 |
LIMB DISCOMFORT |
1 |
0.0000 |
| 356 |
FEMUR FRACTURE |
1 |
0.0000 |
| 357 |
SWOLLEN TONGUE |
1 |
0.0000 |
| 358 |
DIARRHOEA |
20 |
0.0000 |
| 359 |
MYALGIA |
5 |
0.0000 |
| 360 |
PYREXIA |
10 |
0.0000 |
| 361 |
BURNING SENSATION |
2 |
0.0000 |
| 362 |
FATIGUE |
22 |
0.0000 |
| 363 |
LYMPHADENOPATHY |
1 |
0.0000 |
| 364 |
ANXIETY |
8 |
0.0000 |
| 365 |
INCORRECT ROUTE OF DRUG ADMINISTRATION |
1 |
0.0000 |
| 366 |
VOMITING |
13 |
0.0000 |
| 367 |
NO ADVERSE EVENT |
5 |
0.0000 |
| 368 |
CONSTIPATION |
6 |
0.0000 |
| 369 |
DYSPNOEA EXERTIONAL |
1 |
0.0000 |
| 370 |
CHRONIC KIDNEY DISEASE |
2 |
0.0000 |
| 371 |
ANAEMIA |
5 |
0.0000 |
| 372 |
ACUTE KIDNEY INJURY |
4 |
0.0000 |
| 373 |
HEADACHE |
16 |
0.0000 |
| 374 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
1 |
0.0000 |
| 375 |
OEDEMA PERIPHERAL |
3 |
0.0000 |
| 376 |
POLLAKIURIA |
1 |
0.0000 |
| 377 |
ROAD TRAFFIC ACCIDENT |
1 |
0.0000 |
| 378 |
RECTAL HAEMORRHAGE |
1 |
0.0000 |
| 379 |
VAGINAL HAEMORRHAGE |
1 |
0.0000 |
| 380 |
TACHYCARDIA |
2 |
0.0000 |
| 381 |
THERAPY NON-RESPONDER |
1 |
0.0000 |
| 382 |
TINNITUS |
1 |
0.0000 |
| 383 |
COUGH |
6 |
0.0000 |
| 384 |
COMA |
1 |
0.0000 |
| 385 |
PRURITUS |
8 |
0.0000 |
| 386 |
LEUKOPENIA |
1 |
0.0000 |
| 387 |
HYPOTENSION |
4 |
0.0000 |
| 388 |
FLUID RETENTION |
1 |
0.0000 |
| 389 |
CHEST DISCOMFORT |
2 |
0.0000 |
| 390 |
MALIGNANT NEOPLASM PROGRESSION |
2 |
0.0000 |
| 391 |
DEPRESSED MOOD |
1 |
0.0000 |
| 392 |
ANAPHYLACTIC REACTION |
1 |
0.0000 |
| 393 |
SEPSIS |
2 |
0.0000 |
| 394 |
WEIGHT DECREASED |
5 |
0.0000 |
| 395 |
FLATULENCE |
1 |
0.0000 |
| 396 |
CONVULSION |
1 |
0.0000 |
| 397 |
THERAPEUTIC RESPONSE DECREASED |
1 |
0.0000 |
| 398 |
FEELING HOT |
1 |
0.0000 |
| 399 |
VISUAL IMPAIRMENT |
2 |
0.0000 |
| 400 |
GAIT DISTURBANCE |
3 |
0.0000 |
| 401 |
LOSS OF CONSCIOUSNESS |
2 |
0.0000 |
| 402 |
AMNESIA |
1 |
0.0000 |
| 403 |
RENAL FAILURE |
2 |
0.0000 |
| 404 |
RESPIRATORY FAILURE |
1 |
0.0000 |
| 405 |
DYSGEUSIA |
1 |
0.0000 |
| 406 |
DEATH |
11 |
0.0000 |
| 407 |
ARTHRITIS |
1 |
0.0000 |
| 408 |
DRUG ABUSE |
1 |
0.0000 |
| 409 |
BALANCE DISORDER |
1 |
0.0000 |
| 410 |
COVID-19 |
2 |
0.0000 |
| 411 |
SUICIDAL IDEATION |
1 |
0.0000 |
| 412 |
BLOOD GLUCOSE INCREASED |
2 |
0.0000 |
| 413 |
DYSPHAGIA |
1 |
0.0000 |
| 414 |
ATRIAL FIBRILLATION |
1 |
0.0000 |
| 415 |
HEART RATE INCREASED |
1 |
0.0000 |
| 416 |
ERYTHEMA |
2 |
0.0000 |
| 417 |
ILLNESS |
1 |
0.0000 |
| 418 |
THROMBOCYTOPENIA |
1 |
0.0000 |
| 419 |
ASTHMA |
1 |
0.0000 |
| 420 |
PSORIASIS |
1 |
0.0000 |
| 421 |
DEHYDRATION |
1 |
0.0000 |
| 422 |
VISION BLURRED |
1 |
0.0000 |
| 423 |
TOXICITY TO VARIOUS AGENTS |
1 |
0.0000 |
| 424 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
1 |
0.0000 |
| 425 |
CHEST PAIN |
1 |
0.0000 |
| 426 |
SOMNOLENCE |
1 |
0.0000 |
| 427 |
BACK PAIN |
1 |
0.0000 |
| 428 |
FEELING ABNORMAL |
1 |
0.0000 |